Skip to main content

XL413 . HCl

ENZ-CHM453

  • ENZ-CHM453-0025   —   25 mg
    $478.00

XL413 is a potent ATP-competitive inhibitor of the important DNA replication initiation kinase Cdc7 (DDK). It increases the efficiency of homology directed DNA repair in CRISPR-Cas9 gene editing. XL413 acted synergistically with other chemotherapy agents in various cancer models.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only


Resources